Global Gastrointestinal Cancer Treatment Market Research Report 2023

Publisher Name :
Date: 27-Jan-2023
No. of pages: 96
Inquire Before Buying

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.

Highlights

The global Gastrointestinal Cancer Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The global gastrointestinal cancer drugs market is driven by growth in prevalence of gastrointestinal cancer, increase in demand for targeted drug delivery, rise in public awareness, government initiatives to eliminate cancer, and patent expiry of key cancer drugs

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Cancer Treatment.

The Gastrointestinal Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gastrointestinal Cancer Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Eli Lilly

- F. Hoffmann

- GlaxoSmithKline

- Merck

- Novartis AG

- Otsuka Holdings

- Stryker Corporation

- Boston Scientific Corporation

- Johnson and Johnson

- CONMED Corporation

- Bristol-Myers Squibb

- Pfizer

- Celltrion Inc

- Amgen Limited

- Celgene Corporation

- Sanofi

Segment by Type

- Surgery

- Targeted Drugs Therapy

- Chemo Therapy

- Adjuvant Chemotherapy

- Radiation Therapy

Segment by Application

- Hospitals

- Clinics

- Research Centers

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal Cancer Treatment companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Gastrointestinal Cancer Treatment Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Surgery
1.2.3 Targeted Drugs Therapy
1.2.4 Chemo Therapy
1.2.5 Adjuvant Chemotherapy
1.2.6 Radiation Therapy
1.3 Market by Application
1.3.1 Global Gastrointestinal Cancer Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2018-2029)
2.2 Gastrointestinal Cancer Treatment Growth Trends by Region
2.2.1 Global Gastrointestinal Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gastrointestinal Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2024-2029)
2.3 Gastrointestinal Cancer Treatment Market Dynamics
2.3.1 Gastrointestinal Cancer Treatment Industry Trends
2.3.2 Gastrointestinal Cancer Treatment Market Drivers
2.3.3 Gastrointestinal Cancer Treatment Market Challenges
2.3.4 Gastrointestinal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue
3.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2018-2023)
3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue
3.4 Global Gastrointestinal Cancer Treatment Market Concentration Ratio
3.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2022
3.5 Gastrointestinal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Gastrointestinal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Cancer Treatment Breakdown Data by Type
4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2024-2029)
5 Gastrointestinal Cancer Treatment Breakdown Data by Application
5.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gastrointestinal Cancer Treatment Market Size (2018-2029)
6.2 North America Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
6.4 North America Gastrointestinal Cancer Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Cancer Treatment Market Size (2018-2029)
7.2 Europe Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
7.4 Europe Gastrointestinal Cancer Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size (2018-2029)
8.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Cancer Treatment Market Size (2018-2029)
9.2 Latin America Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
9.4 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size (2018-2029)
10.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction
11.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 F. Hoffmann
11.2.1 F. Hoffmann Company Detail
11.2.2 F. Hoffmann Business Overview
11.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction
11.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.2.5 F. Hoffmann Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Gastrointestinal Cancer Treatment Introduction
11.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction
11.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.5.5 Novartis AG Recent Development
11.6 Otsuka Holdings
11.6.1 Otsuka Holdings Company Detail
11.6.2 Otsuka Holdings Business Overview
11.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction
11.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.6.5 Otsuka Holdings Recent Development
11.7 Stryker Corporation
11.7.1 Stryker Corporation Company Detail
11.7.2 Stryker Corporation Business Overview
11.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction
11.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.7.5 Stryker Corporation Recent Development
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Detail
11.8.2 Boston Scientific Corporation Business Overview
11.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction
11.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.8.5 Boston Scientific Corporation Recent Development
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Detail
11.9.2 Johnson and Johnson Business Overview
11.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction
11.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.9.5 Johnson and Johnson Recent Development
11.10 CONMED Corporation
11.10.1 CONMED Corporation Company Detail
11.10.2 CONMED Corporation Business Overview
11.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction
11.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.10.5 CONMED Corporation Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction
11.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.12.5 Pfizer Recent Development
11.13 Celltrion Inc
11.13.1 Celltrion Inc Company Detail
11.13.2 Celltrion Inc Business Overview
11.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction
11.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.13.5 Celltrion Inc Recent Development
11.14 Amgen Limited
11.14.1 Amgen Limited Company Detail
11.14.2 Amgen Limited Business Overview
11.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction
11.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.14.5 Amgen Limited Recent Development
11.15 Celgene Corporation
11.15.1 Celgene Corporation Company Detail
11.15.2 Celgene Corporation Business Overview
11.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction
11.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.15.5 Celgene Corporation Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Detail
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction
11.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.16.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Surgery
Table 3. Key Players of Targeted Drugs Therapy
Table 4. Key Players of Chemo Therapy
Table 5. Key Players of Adjuvant Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Global Gastrointestinal Cancer Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Gastrointestinal Cancer Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Gastrointestinal Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Gastrointestinal Cancer Treatment Market Share by Region (2018-2023)
Table 11. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Gastrointestinal Cancer Treatment Market Share by Region (2024-2029)
Table 13. Gastrointestinal Cancer Treatment Market Trends
Table 14. Gastrointestinal Cancer Treatment Market Drivers
Table 15. Gastrointestinal Cancer Treatment Market Challenges
Table 16. Gastrointestinal Cancer Treatment Market Restraints
Table 17. Global Gastrointestinal Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Gastrointestinal Cancer Treatment Market Share by Players (2018-2023)
Table 19. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2022)
Table 20. Ranking of Global Top Gastrointestinal Cancer Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Gastrointestinal Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastrointestinal Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Gastrointestinal Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2024-2029)
Table 34. North America Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Gastrointestinal Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Eli Lilly Company Detail
Table 50. Eli Lilly Business Overview
Table 51. Eli Lilly Gastrointestinal Cancer Treatment Product
Table 52. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 53. Eli Lilly Recent Development
Table 54. F. Hoffmann Company Detail
Table 55. F. Hoffmann Business Overview
Table 56. F. Hoffmann Gastrointestinal Cancer Treatment Product
Table 57. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 58. F. Hoffmann Recent Development
Table 59. GlaxoSmithKline Company Detail
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Gastrointestinal Cancer Treatment Product
Table 62. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck Gastrointestinal Cancer Treatment Product
Table 67. Merck Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Novartis AG Company Detail
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Gastrointestinal Cancer Treatment Product
Table 72. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. Otsuka Holdings Company Detail
Table 75. Otsuka Holdings Business Overview
Table 76. Otsuka Holdings Gastrointestinal Cancer Treatment Product
Table 77. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 78. Otsuka Holdings Recent Development
Table 79. Stryker Corporation Company Detail
Table 80. Stryker Corporation Business Overview
Table 81. Stryker Corporation Gastrointestinal Cancer Treatment Product
Table 82. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 83. Stryker Corporation Recent Development
Table 84. Boston Scientific Corporation Company Detail
Table 85. Boston Scientific Corporation Business Overview
Table 86. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product
Table 87. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 88. Boston Scientific Corporation Recent Development
Table 89. Johnson and Johnson Company Detail
Table 90. Johnson and Johnson Business Overview
Table 91. Johnson and Johnson Gastrointestinal Cancer Treatment Product
Table 92. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 93. Johnson and Johnson Recent Development
Table 94. CONMED Corporation Company Detail
Table 95. CONMED Corporation Business Overview
Table 96. CONMED Corporation Gastrointestinal Cancer Treatment Product
Table 97. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 98. CONMED Corporation Recent Development
Table 99. Bristol-Myers Squibb Company Detail
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product
Table 102. Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Pfizer Company Detail
Table 105. Pfizer Business Overview
Table 106. Pfizer Gastrointestinal Cancer Treatment Product
Table 107. Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Celltrion Inc Company Detail
Table 110. Celltrion Inc Business Overview
Table 111. Celltrion Inc Gastrointestinal Cancer Treatment Product
Table 112. Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 113. Celltrion Inc Recent Development
Table 114. Amgen Limited Company Detail
Table 115. Amgen Limited Business Overview
Table 116. Amgen Limited Gastrointestinal Cancer Treatment Product
Table 117. Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 118. Amgen Limited Recent Development
Table 119. Celgene Corporation Company Detail
Table 120. Celgene Corporation Business Overview
Table 121. Celgene Corporation Gastrointestinal Cancer Treatment Product
Table 122. Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 123. Celgene Corporation Recent Development
Table 124. Sanofi Company Detail
Table 125. Sanofi Business Overview
Table 126. Sanofi Gastrointestinal Cancer Treatment Product
Table 127. Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 128. Sanofi Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Cancer Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gastrointestinal Cancer Treatment Market Share by Type: 2022 VS 2029
Figure 3. Surgery Features
Figure 4. Targeted Drugs Therapy Features
Figure 5. Chemo Therapy Features
Figure 6. Adjuvant Chemotherapy Features
Figure 7. Radiation Therapy Features
Figure 8. Global Gastrointestinal Cancer Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Gastrointestinal Cancer Treatment Market Share by Application: 2022 VS 2029
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Gastrointestinal Cancer Treatment Report Years Considered
Figure 15. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Gastrointestinal Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Gastrointestinal Cancer Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Gastrointestinal Cancer Treatment Market Share by Players in 2022
Figure 19. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2022
Figure 21. North America Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)
Figure 23. United States Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)
Figure 27. Germany Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Region (2018-2029)
Figure 35. China Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 50. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 53. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 54. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 55. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 56. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 57. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 58. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 61. Celltrion Inc Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 62. Amgen Limited Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 63. Celgene Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 64. Sanofi Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Ultrasound Probe Disinfection Market by Product (Instrument, Services, Consumables (Disinfectants & Detergents)), Probe Type (Linear, Convex, & TEE Transducers),Process (High-Level & Low-Level Disinfection), End User (Hospitals) - Global Forecast to 2027
    Published: 17-Mar-2023        Price: US 4950 Onwards        Pages: 290
    “Global ultrasound probe disinfection market to register a CAGR of 13.3 % from 2022 to 2027” The global ultrasound probe disinfection market is projected to reach USD 936 million by 2027 from USD 501 million in 2022, at a CAGR of 13.3% during the forecast period. Growth in this market is mainly driven by the increasing incidence of hospital-acquired infections (HAIs) due to improper reprocessing of ultrasound probes, and government regulations and guidelin......
  • Global Mrsa Testing Devices Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 109
    The Mrsa Testing Devices market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Mrsa Testing Devices industry, and breaks down according to the type, application, and consumption area of Mrsa Testing Devices. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and descr......
  • Global Coronary Guidewires Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 100
    The Coronary Guidewires market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Coronary Guidewires industry, and breaks down according to the type, application, and consumption area of Coronary Guidewires. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Global Lateral Flow POC Reader Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 123
    The Lateral Flow POC Reader market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Lateral Flow POC Reader industry, and breaks down according to the type, application, and consumption area of Lateral Flow POC Reader. The report also introduces players in the industry from the perspective of the industry chain and marketing chain ......
  • Global Infrared Thermometer Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 103
    The Infrared Thermometer market revenue was 2567.96 Million USD in 2022, and will reach 4096.2 Million USD in 2028, with a CAGR of 8.09% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Infrared Thermometer industry, and breaks down according to the type, application, and consumption area of Infrared Thermometer. The report also introduces players in the industry from the perspective of the industry chain and marketing chai......
  • Global Infertility Treatment Devices Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Infertility Treatment Devices market revenue was 399.39 Million USD in 2022, and will reach 662.62 Million USD in 2028, with a CAGR of 8.8% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Infertility Treatment Devices industry, and breaks down according to the type, application, and consumption area of Infertility Treatment Devices. The report also introduces players in the industry from the perspective of the industry......
  • Global Endoscopy Visualization System Components Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 117
    The Endoscopy Visualization System Components market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Endoscopy Visualization System Components industry, and breaks down according to the type, application, and consumption area of Endoscopy Visualization System Components. The report also introduces players in the industry from the ......
  • Global Medical Kits And Trays Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 129
    The Medical Kits And Trays market revenue was 12355.6 Million USD in 2022, and will reach 19215.54 Million USD in 2028, with a CAGR of 7.64% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Medical Kits And Trays industry, and breaks down according to the type, application, and consumption area of Medical Kits And Trays. The report also introduces players in the industry from the perspective of the industry chain and market......
  • Global Elastic Therapeutic Tape Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 120
    The Elastic therapeutic tape is an elastic cotton strip with an acrylic adhesive that is used with the intent of treating pain and disability from athletic injuries and a variety of other physical disorders. The Elastic Therapeutic Tape market revenue was 264.16 Million USD in 2022, and will reach 511.88 Million USD in 2028, with a CAGR of 11.66% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Elastic Therapeutic Ta......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs